These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21353073)

  • 21. [Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity].
    Chenet A; Perrouin-Verbe B; Le Normand L; Labat JJ; Brunel P; Lefort M; Mathé JF
    Ann Readapt Med Phys; 2007 Nov; 50(8):651-60. PubMed ID: 17490775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The medical management of urinary incontinence.
    Shaban A; Drake MJ; Hashim H
    Auton Neurosci; 2010 Jan; 152(1-2):4-10. PubMed ID: 19900845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment for stress and urge urinary incontinence.
    Wai CY
    Obstet Gynecol Clin North Am; 2009 Sep; 36(3):509-19. PubMed ID: 19932413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.
    Abdel-Meguid TA
    J Urol; 2010 Dec; 184(6):2423-8. PubMed ID: 20952003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of functional continuous magnetic stimulation for urinary incontinence.
    Yamanishi T; Yasuda K; Suda S; Ishikawa N; Sakakibara R; Hattori T
    J Urol; 2000 Feb; 163(2):456-9. PubMed ID: 10647653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What are the necessary practice competencies for two providers: dermal fillers and botulinum toxin type A injections?
    Spear M
    Plast Surg Nurs; 2010; 30(4):226-46; quiz 247-8. PubMed ID: 21217370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canadian Urological Association guidelines on urinary incontinence.
    Corcos J; Gajewski J; Heritz D; Patrick A; Reid I; Schick E; Stothers L;
    Can J Urol; 2006 Jun; 13(3):3127-38. PubMed ID: 16813704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical electromotive botulinum toxin type A administration--part II: Clinical application.
    Kajbafzadeh AM; Ahmadi H; Montaser-Kouhsari L; Sharifi-Rad L; Nejat F; Bazargan-Hejazi S
    Urology; 2011 Feb; 77(2):439-45. PubMed ID: 20800886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urethral bulking agents.
    McGuire EJ
    Nat Clin Pract Urol; 2006 May; 3(5):234-5. PubMed ID: 16691215
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
    West TB
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
    [No Abstract]   [Full Text] [Related]  

  • 32. Rationale of pelvic floor muscles training in women with urinary incontinence.
    Di Benedetto P; Coidessa A; Floris S
    Minerva Ginecol; 2008 Dec; 60(6):529-41. PubMed ID: 18981979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Input from a specialized nurse consultation in the management of detrusor overactivity treated with intradetrusor injections of botulinum toxin in urology department. Pilot study].
    Le Gal S; Safsaf A; Galliot I; Catovic B; Grise P
    Prog Urol; 2010 Sep; 20(8):584-9. PubMed ID: 20832036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment options for female urinary incontinence--a review.
    Davila GW; Guerette N
    Int J Fertil Womens Med; 2004; 49(3):102-12. PubMed ID: 15303311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence.
    Kim IG; Oh SH; Lee JY; Lee JY; Lee JH
    Tissue Eng Part A; 2011 Jun; 17(11-12):1527-35. PubMed ID: 21275847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TVT and concomitant intra-detrusor botox injection for women with mixed urinary incontinence: Is it a good idea?].
    Deffieux X
    Prog Urol; 2021 Mar; 31(4):184-185. PubMed ID: 33714425
    [No Abstract]   [Full Text] [Related]  

  • 38. Treating urethral sphincter damage caused by long-term urethral catheterisation with a Zuidex periurethral injection and suprapubic catheter.
    Papanikolaou NS; Duckett J
    J Obstet Gynaecol; 2008 Apr; 28(3):361-2. PubMed ID: 18569498
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.